Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Meeting, 17862-17863 [2023-06155]

Download as PDF 17862 Federal Register / Vol. 88, No. 57 / Friday, March 24, 2023 / Notices ESTIMATED ANNUALIZED BURDEN HOUR TABLE Number of responses per respondents Forms (if necessary) Respondents (if necessary) PHS–6349 ..................................... PHS–6315 ..................................... Awardee Institutions ..................... Sub-Awardee Institutions ............. 5,770 156 1 1 10/60 5/60 961 13 Total ....................................... ....................................................... ........................ ............................ ............................ ........................ Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. Number of respondents [FR Doc. 2023–06161 Filed 3–23–23; 8:45 am] Dated: March 20, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4150–31–P [FR Doc. 2023–06086 Filed 3–23–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review; Notice of Closed Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cardiovascular and Surgical Devices and Medical Imaging. Date: April 5, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Willard Wilson, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301–867–5309, willard.wilson@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) VerDate Sep<11>2014 19:18 Mar 23, 2023 Jkt 259001 Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Board on Medical Rehabilitation Research. The meeting will be held as a hybrid (in person and virtual) meeting and is open to the public. Individuals who plan to attend as well as those who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed as below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting website (https://videocast.nih.gov). Name of Committee: National Advisory Board on Medical Rehabilitation Research. Date: May 1–2, 2023. Time: May 1, 2023, 9:00 a.m. to 5:00 p.m. Agenda: NCMRR Director’s report; NCMRR Portfolio Analysis; Report out on NCMRR Conferences; Research Talk: Therapeutic Strategies to Maximize Development in Children with Neuromotor Disorders; Research Talk: Neural and Biomechanical Contributors to Posture and Movement; Training and Career Development Breakout Groups. Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, MPR, Bethesda, MD 20892–7510. Time: May 2, 2023, 9:00 a.m. to 12:30 p.m. Agenda: NICHD Director’s report; Report out from Breakout Groups and Training Work Group formation; Science Talk: Knowledge Translation; Concept Clearance; Comments from Retiring Board Members; Planning for Next Board Meeting in December 2023. PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 Average burden per response Total burden hours Place: Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, MPR, Bethesda, MD 20892–7510. Contact Person: Ralph M. Nitkin, Ph.D., Deputy, National Center for Medical Rehabilitation Research and Director, Biological Sciences and Career Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6710B Rockledge Drive, Room 2116, Bethesda, MD 20892–7510, (301) 402–4206, nitkinr@mail.nih.gov. In the interest of security, NIH has procedures at https://www.nih.gov/ about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID–19 Safety Plan at https://ors.od.nih.gov/sr/ dohs/safety/NIH-covid-19-safety-plan/ Pages/default.aspx for information about requirements and procedures for entering NIH facilities, especially when COVID–19 community levels are medium or high. In addition, the Safer Federal Workforce website has FAQs for visitors at https:// www.saferfederalworkforce.gov/faq/ visitors/. Please note that if an individual has a COVID–19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH’s Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/ NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/persons-afterexposure.aspx and What Happens When Someone Tests Positive at https:// ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVIDassessment-testing/Pages/test- E:\FR\FM\24MRN1.SGM 24MRN1 Federal Register / Vol. 88, No. 57 / Friday, March 24, 2023 / Notices positive.aspx.) Anyone from the public can attend the open portion of the meeting virtually via the NIH Videocasting website (https:// videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up to date guidance as the meeting date approaches. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/advisory/ nabmrr, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: March 21, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–06155 Filed 3–23–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Meeting of the Substance Abuse and Mental Health Services Administration National Advisory Council Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: Notice is hereby given for the meeting on April 27, 2023, of the Substance Abuse and Mental Health Services Administration National Advisory Council (SAMHSA NAC). The meeting is open to the public and can also be accessed virtually. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at: https://www.samhsa.gov/about-us/ advisory-councils/meetings. The meeting will include, but not be limited to, remarks from the Assistant Secretary for Mental Health and Substance Use; approval of the meeting minutes of August 10, 2022; updates and recap of the joint meetings of the councils (JNAC) and Lessons Learned; presentations on initiatives by the National Mental Health and Policy Laboratory; update on the Strategic Plan and Public Comment Response; and Overview of the Evidence-Based Practices Resource Center with group discussion; a presentation and lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 19:18 Mar 23, 2023 Jkt 259001 discussion regarding the integration of equity; updates on the Interagency Task Force on Trauma Informed Care; updates on the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC); updates on the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC); Council discussion and public comments. DATES: March 27, 2023, 10:00 a.m. to approximately 3:15 p.m. EDT, Open. ADDRESSES: 5600 Fishers Lane, Rockville, Maryland 20857 (Pavilion rooms). FOR FURTHER INFORMATION CONTACT: Carlos Castillo, Committee Management Officer and Designated Federal Official; SAMHSA National Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail); telephone: (240) 276– 2787; email: carlos.castillo@ samhsa.hhs.gov. The SAMHSA NAC was established to advise the Secretary, Department of Health and Human Services (HHS), and the Assistant Secretary for Mental Health and Substance Use, SAMHSA, to improve the provision of treatments and related services to individuals with respect to substance use and to improve prevention services, promote mental health, and protect legal rights of individuals with mental illness and individuals with substance use disorders or misuse. Interested persons may present data, information, or views orally or in writing, on issues pending before the Council. Written submissions must be forwarded to the contact person no later than 7 days before the meeting. Oral presentations from the public will be scheduled for the public comment section at the end of the council discussion. Individuals interested in making oral presentations must notify the contact person by 1:00 p.m. (EDT), April 19, 2023. Up to three minutes will be allotted for each presentation, and as time permits, as these are presented in the order received. Public comments received will become part of the meeting records. To obtain the call-in number, access code, and/or web access link; submit written or brief oral comments; or request special accommodations for persons with disabilities, please register on-line at: https://snacregister. samhsa.gov, or communicate with the contact person. Meeting information and a roster of Council members may be obtained either by accessing the SAMHSA Council’s website at https:// SUPPLEMENTARY INFORMATION: PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 17863 www.samhsa.gov/about-us/advisorycouncils/, or by contacting Carlos Castillo. Dated: March 21, 2023. Carlos Castillo, Committee Management Officer. [FR Doc. 2023–06153 Filed 3–23–23; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Joint Meeting of the National Advisory Councils Substance Abuse and Mental Health Services Administration, Department of Health and Human Services. ACTION: Notice. AGENCY: Notice is hereby given of the combined (joint) meeting on April 26, 2023, of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) four National Advisory Councils: the SAMHSA National Advisory Council (NAC), the Center for Mental Health Services NAC, the Center for Substance Abuse Prevention NAC, the Center for Substance Abuse Treatment NAC; and the two SAMHSA Advisory Committees: Advisory Committee for Women’s Services (ACWS) and the Tribal Technical Advisory Committee (TTAC). SUMMARY: Written submissions should be forwarded to the contact person by April 15, 2023. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations must notify the contact by April 15, 2023. Up to three minutes will be allotted for each presentation, as time permits. DATES: The meeting is open to the public and will be held at the Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Attendance by the public will be limited to space available. Interested persons may present data, information, or views orally or in writing, on issues pending before the Council. The meeting may be accessed via telephone and remotely via Zoom platform. To attend on site, obtain the call-in number, access code, and/or web access link; submit written or brief oral comments; or request special accommodations for persons with ADDRESSES: E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 88, Number 57 (Friday, March 24, 2023)]
[Notices]
[Pages 17862-17863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06155]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Board on Medical Rehabilitation Research.
    The meeting will be held as a hybrid (in person and virtual) 
meeting and is open to the public. Individuals who plan to attend as 
well as those who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed as below in advance of the meeting. The meeting 
will be videocast and can be accessed from the NIH Videocasting website 
(https://videocast.nih.gov).

    Name of Committee: National Advisory Board on Medical 
Rehabilitation Research.
    Date: May 1-2, 2023.
    Time: May 1, 2023, 9:00 a.m. to 5:00 p.m.
    Agenda: NCMRR Director's report; NCMRR Portfolio Analysis; 
Report out on NCMRR Conferences; Research Talk: Therapeutic 
Strategies to Maximize Development in Children with Neuromotor 
Disorders; Research Talk: Neural and Biomechanical Contributors to 
Posture and Movement; Training and Career Development Breakout 
Groups.
    Place: Eunice Kennedy Shriver National Institute of Child Health 
and Human Development, National Institutes of Health, 6710B 
Rockledge Drive, MPR, Bethesda, MD 20892-7510.

    Time: May 2, 2023, 9:00 a.m. to 12:30 p.m.
    Agenda: NICHD Director's report; Report out from Breakout Groups 
and Training Work Group formation; Science Talk: Knowledge 
Translation; Concept Clearance; Comments from Retiring Board 
Members; Planning for Next Board Meeting in December 2023.
    Place: Eunice Kennedy Shriver National Institute of Child Health 
and Human Development, National Institutes of Health, 6710B 
Rockledge Drive, MPR, Bethesda, MD 20892-7510.
    Contact Person: Ralph M. Nitkin, Ph.D., Deputy, National Center 
for Medical Rehabilitation Research and Director, Biological 
Sciences and Career Development Program, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, National 
Institutes of Health, 6710B Rockledge Drive, Room 2116, Bethesda, MD 
20892-7510, (301) 402-4206, [email protected].

    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a meeting 
on campus or at an off-campus federal facility will be asked to show 
one form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their visit.
    Additional Health and Safety Guidance: Before attending a meeting 
at an NIH facility, it is important that visitors review the NIH COVID-
19 Safety Plan at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/Pages/default.aspx for information about requirements and 
procedures for entering NIH facilities, especially when COVID-19 
community levels are medium or high. In addition, the Safer Federal 
Workforce website has FAQs for visitors at https://www.saferfederalworkforce.gov/faq/visitors/. Please note that if an 
individual has a COVID-19 diagnosis within 10 days of the meeting, that 
person must attend virtually. (For more information please read NIH's 
Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-plan/COVID-assessment-testing/Pages/persons-after-exposure.aspx and What Happens When Someone Tests 
Positive at https://ors.od.nih.gov/sr/dohs/safety/NIH-covid-19-safety-
plan/COVID-assessment-testing/Pages/test-

[[Page 17863]]

positive.aspx.) Anyone from the public can attend the open portion of 
the meeting virtually via the NIH Videocasting website (https://videocast.nih.gov). Please continue checking these websites, in 
addition to the committee website listed below, for the most up to date 
guidance as the meeting date approaches.
    Information is also available on the Institute's/Center's home 
page: https://www.nichd.nih.gov/about/advisory/nabmrr, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: March 21, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-06155 Filed 3-23-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.